EPCAM and Merkel cell skin cancer: When co-cultured with TPR/IL2-expanded PBMCs, EpCAM-ReTARGTPRIFNαR149A induced a marked 3-fold reduction in MCC cell number compared to EpCAM-ReTARGTPR (Figure 5C).